THE TRENDLINES GROUP LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.069 SGD | -6.76% |
|
-1.43% | -24.18% |
| Sales 2022 | 2.37M 3.23M | Sales 2023 | -20.99M -28.57M | Capitalization | 66.23M 90.17M |
|---|---|---|---|---|---|
| Net income 2022 | -14M -19.06M | Net income 2023 | -34M -46.29M | EV / Sales 2022 | 25.1 x |
| Net cash position 2022 | 3.1M 4.22M | Net cash position 2023 | 1.47M 2M | EV / Sales 2023 | -3.09 x |
| P/E ratio 2022 |
-3.58
x | P/E ratio 2023 |
-1.72
x | Employees | 24 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 34.98% |
More Fundamentals
* Assessed data
More news
Latest transcript on The Trendlines Group Ltd.
More press releases
| 1 day | -6.76% | ||
| 1 week | -1.43% | ||
| Current month | -13.75% | ||
| 1 month | -16.87% | ||
| 3 months | -20.69% | ||
| 6 months | -18.82% | ||
| Current year | -24.18% |
1 week
0.06
0.07
1 month
0.060.08
Current year
0.060.09
1 year
0.060.11
3 years
0.060.12
5 years
0.050.14
10 years
0.050.40
| Managers | Title | Age | Since |
|---|---|---|---|
Haim Brosh
CEO | Chief Executive Officer | 57 | 13-12-31 |
| Chief Operating Officer | - | - | |
Shahar Harari
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Elka Nir
BRD | Director/Board Member | 63 | 15-10-14 |
Nehama Ronen
CHM | Chairman | 62 | 22-06-05 |
Boon Ann Sin
BRD | Director/Board Member | 66 | 20-06-16 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-17 | 0.069 | -6.76% | 100,000 |
| 24-04-15 | 0.074 | +5.71% | 292,700 |
| 24-04-12 | 0.07 | -2.78% | 45,000 |
Delayed Quote Singapore S.E., April 17, 2024 at 04:12 am EDT
More quotes
Trendlines Group Ltd is an Israel-based life sciences innovation commercialization company, which invents, discovers, invests in, partners and incubates innovation based medical and agricultural technologies. It invests principally through four business units: two Israeli government-franchised incubators, Trendlines Medical and Trendlines Agtech, a Singapore incubator, Trendlines Medical Singapore, and an in-house innovation center, Trendlines Labs. The Groupâ s portfolio include more than 50 companies engaged with medical and agricultural technologies and products. The Group is involved in all aspects of its portfolio companies from technology development to business building. The Group in partnerships with entrepreneurs, investors, strategic players, inventors, and governments aims to improve the human condition.
Calendar
2024-08-06
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -24.18% | 48.68M | |
| +31.41% | 12.02B | |
| +10.74% | 2.93B | |
| +2.96% | 1.4B | |
| -8.46% | 1.22B | |
| +43.91% | 624M | |
| -0.80% | 597M | |
| -19.31% | 518M | |
| +33.70% | 493M | |
| -4.17% | 492M |
- Stock Market
- Equities
- 42T Stock
